The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased ...
Wave Life Sciences Ltd. ( WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity December 8, 2025 8:30 AM EST ...
Arrowhead Pharmaceuticals, Inc. today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company's investigational RNA interference (RNAi) therapeutic being ...
Could a dusty rock hurtling through space hold the recipe for life? NASA’s latest analysis of asteroid Bennu’s pristine ...
Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...
A webcast of the conference call can be accessed by visiting “Investor Events” on the investor relations section of the Wave Life Sciences website: ...
The CDC Advisory Committee on Immunization Practices met last week, eliminating the universal recommendation for the birth dose of the hepatitis B vaccine. There was, however, a more insidious threat ...